rs9829896 regulates KAT2B
Evidence from:
primary |
all sources
Evidence (5 sources)
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896-KAT2B expression analysis of the BrainCloud data resulted in a P value that fell just at the 0.05 threshold
confidence: 0.90
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
expression of both genes was down-regulated by the protective allele for drug abuse, rs9829896-C
confidence: 0.94
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896-C allele was associated with lower KAT2B expression in AAs (P=0.050) but not in EAs (P=0.39).
confidence: 0.96
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896-C allele ... reduced KAT2B ... expression
confidence: 0.94
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
We implicated rs9829896 as a cis-eQTL for the KAT2B gene
confidence: 0.90